This is a Validated Antibody Database (VAD) review about rat Pfkl, based on 3 published articles (read how Labome selects the articles), using Pfkl antibody in all methods. It is aimed to help Labome visitors find the most suited Pfkl antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Pfkl synonym: ATP-PFK; PFK-L

Abcam
domestic rabbit monoclonal (EPR11904)
  • proximity ligation assay; human; 1:1000; loading ...; fig 2f
  • immunoprecipitation; human; loading ...; fig 4e
  • immunocytochemistry; human; 1:1000; loading ...; fig 2e
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam Pfkl antibody (Abcam, ab181064) was used in proximity ligation assay on human samples at 1:1000 (fig 2f), in immunoprecipitation on human samples (fig 4e), in immunocytochemistry on human samples at 1:1000 (fig 2e) and in western blot on human samples at 1:1000 (fig 3a). Cell Death Dis (2020) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1c
In order to assess if aerobic glycolysis and glutaminolysis co-operatively reduce UDP-GlcNAc biosynthesis and N-glycan branching in mouse T cell blasts, Cell Signaling Technology Pfkl antibody (Cell Signaling, 8175) was used in western blot on mouse samples (fig 1c). elife (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4g
  • western blot; mouse; 1:1000; fig 6l
Cell Signaling Technology Pfkl antibody (Cell Signaling Technology, 8175) was used in western blot on human samples at 1:1000 (fig 4g) and in western blot on mouse samples at 1:1000 (fig 6l). FASEB J (2016) ncbi
Articles Reviewed
  1. Feng Y, Zhang Y, Cai Y, Liu R, Lu M, Li T, et al. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma. Cell Death Dis. 2020;11:89 pubmed publisher
  2. Araujo L, Khim P, Mkhikian H, Mortales C, Demetriou M. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. elife. 2017;6: pubmed publisher
  3. Sharma B, Kolhe R, Black S, Keller J, Mivechi N, Satyanarayana A. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells. FASEB J. 2016;30:262-75 pubmed publisher